2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

[HTML][HTML] Reference ranges (“normal values”) for cardiovascular magnetic resonance (CMR) in adults and children: 2025 update

N Kawel-Boehm, SJ Hetzel… - Journal of …, 2025 - Elsevier
Quantitative assessment of morphological and functional cardiac parameters by
cardiovascular magnetic resonance (CMR) is essential for research and routine clinical …

[HTML][HTML] Clinical recommendations for cardiovascular magnetic resonance map** of T1, T2, T2* and extracellular volume: a consensus statement by the Society for …

DR Messroghli, JC Moon, VM Ferreira… - Journal of …, 2016 - Elsevier
Parametric map** techniques provide a non-invasive tool for quantifying tissue alterations
in myocardial disease in those eligible for cardiovascular magnetic resonance (CMR) …

Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature

C Chatre, F Roubille, H Vernhet, C Jorgensen, YM Pers - Drug safety, 2018 - Springer
Introduction Chloroquine and hydroxychloroquine are widely used in the long-term
treatment of connective tissue disease and usually considered safe. However, chloroquine …

[HTML][HTML] Cardiac T1 map** and extracellular volume (ECV) in clinical practice: a comprehensive review

P Haaf, P Garg, DR Messroghli, DA Broadbent… - Journal of …, 2016 - Elsevier
Abstract Cardiovascular Magnetic Resonance is increasingly used to differentiate the
aetiology of cardiomyopathies. Late Gadolinium Enhancement (LGE) is the reference …

[PDF][PDF] 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

PM Elliott, A Anastasakis, MA Borger… - Polish Heart …, 2014 - journals.viamedica.pl
Kardiomiopatie definiuje się jako strukturalne oraz funkcjonalne nieprawidłowości mięśnia
komór, które nie wynikają z niedokrwienia na skutek choroby wieńcowej czy …

An expert consensus document on the management of cardiovascular manifestations of Fabry disease

A Linhart, DP Germain, I Olivotto… - European journal of …, 2020 - Wiley Online Library
Fabry disease (FD) is an X‐linked lysosomal storage disorder caused by pathogenic
variants in the α‐galactosidase A (GLA) gene that leads to reduced or undetectable α …

Хроническая сердечная недостаточность. Клинические рекомендации 2020

СН Терещенко, АС Галявич, ТМ Ускач… - Российский …, 2020 - cyberleninka.ru
КТИ—кардиоторакальный индекс КШ—коронарное шунтирование ЛЖ—левый
желудочек МНО—международное нормализованное отношение МРТ—магнитно …

European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for …

A Pelliccia, S Caselli, S Sharma, C Basso… - European heart …, 2018 - academic.oup.com
Athletic training is associated with a spectrum of morphologic and functional cardiac
adaptations known as 'the athlete's heart'. 1, 2 To the purpose of the present document an …